KOCA, S. S. Et Al. 2021. Longterm Retention Rate of Certolizumab Pegol in Axial Spondyloarthritis is Higher: Data from TURKBIO. EULAR 2021 , 1266-1267.

KOCA, S. S., PEHLİVAN, Y., AKAR, S., ŞENEL, S., Güler, A., SOYSAL GÜNDÜZ, Ö., ... YAZICI, A.(2021). Longterm Retention Rate of Certolizumab Pegol in Axial Spondyloarthritis is Higher: Data from TURKBIO . EULAR 2021 (pp.1266-1267).

KOCA, SÜLEYMAN Et Al. "Longterm Retention Rate of Certolizumab Pegol in Axial Spondyloarthritis is Higher: Data from TURKBIO," EULAR 2021, 2021

KOCA, SÜLEYMAN S. Et Al. "Longterm Retention Rate of Certolizumab Pegol in Axial Spondyloarthritis is Higher: Data from TURKBIO." EULAR 2021 , pp.1266-1267, 2021

KOCA, S. S. Et Al. (2021) . "Longterm Retention Rate of Certolizumab Pegol in Axial Spondyloarthritis is Higher: Data from TURKBIO." EULAR 2021 , pp.1266-1267.

@conferencepaper{conferencepaper, author={SÜLEYMAN SERDAR KOCA Et Al. }, title={Longterm Retention Rate of Certolizumab Pegol in Axial Spondyloarthritis is Higher: Data from TURKBIO}, congress name={EULAR 2021}, city={}, country={}, year={2021}, pages={1266-1267} }